J
Jonathan Mani
Researcher at University of Oklahoma Health Sciences Center
Publications - 1
Citations - 17
Jonathan Mani is an academic researcher from University of Oklahoma Health Sciences Center. The author has contributed to research in topics: Regorafenib & Angiogenesis. The author has an hindex of 1, co-authored 1 publications receiving 4 citations.
Papers
More filters
Journal ArticleDOI
Regorafenib sensitizes human breast cancer cells to radiation by inhibiting multiple kinases and inducing DNA damage.
Meghna Mehta,James Griffith,Janani Panneerselvam,Anish Babu,Jonathan Mani,Terence S. Herman,Rajagopal Ramesh,Anupama Munshi +7 more
TL;DR: The findings demonstrate that Regorafenib enhanced radiosensitivity of breast cancer cells by inhibiting the expression of multiple receptor tyrosine kinases, VEGF-mediated angiogenesis and DNA damage response in TNBC.